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Several factors are known to enhance adult hippocampal neuro-
genesis but a factor capable of inducing a long-lasting neurogenic
enhancement that attenuates age-related neurogenic decay has not
been described. Here, we studied hippocampal neurogenesis fol-
lowing conditional VEGF induction in the adult brain and showed
that a short episode of VEGF exposure withdrawn shortly after the
generation of durable new vessels (but not under conditions where
newly made vessels failed to persist) is sufficient for neurogenesis to
proceed at a markedly elevated level for many months later.
Continual neurogenic increase over several months was not accom-
panied by accelerated exhaustion of the neuronal stem cell (NSC)
reserve, thereby allowing neurogenesis to proceed at a markedly
elevated rate also in old mice. Neurogenic enhancement by VEGF
preconditioningwas, in part, attributed to rescue of age-related NSC
quiescence. Remarkably, VEGF caused extensive NSC remodelling
manifested in transition of the enigmatic NSC terminal arbor onto
long cytoplasmic processes engaging with and spreading over even
remote blood vessels, a configuration reminiscent of early postnatal
“juvenile” NSCs. Together, these findings suggest that VEGF precon-
ditioning might be harnessed for long-term neurogenic enhance-
ment despite continued exposure to an “aged” systemic milieu.
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The reserve of neuronal stem cells (NSCs) in the hippocampaldentate gyrus (DG) continues to produce neuroblasts maturing
into functional neurons after birth. Adult hippocampal neuro-
genesis, however, rapidly declines with age, and in the rodent
brain, it is barely detected beyond 8 mo of age (1–4). Several
factors, including BDNF, FGF, insulin-like growth factor, VEGF,
and others, were shown to enhance the basal level of hippocampal
neurogenesis (reviewed in ref. 5). However, there is no report of a
factor capable of inducing sustained neurogenic enhancement
lasting months after its withdrawal.
It has been shown that age-related decrease in hippocampal
neurogenesis is associated with progressive depletion of the finite
NSC pool due to the fact that neuroblast-producing asymmetrical
NSC divisions can only take place a limited number of times
before their terminal differentiation to astrocytes (2). Sup-
porting the notion of an exhaustible NSC reservoir is also a
study showing that experimentally forced accelerated neuro-
genesis results in premature NSC depletion (6) and a study
showing that experimentally induced epilepsy is associated with
premature NSC exhaustion (7). Balancing this deterministic
view, however, certain genetic manipulations [e.g., experimen-
tal phosphatase and tensin homolog (PTEN) deletion] were
shown to increase NSC number by symmetrical divisions (8). It
thus remains unclear whether there are means to enforce en-
hanced hippocampal neurogenesis for a long period without
necessarily causing premature exhaustion of the NSC reservoir
and a resultant accelerated age-related neurogenic decay.
Stem cells (SCs) in adult organs reside in specialized niches and
continuous communication with niche cells is required for proper
SC function. Physical proximity between SCs and blood vessels
(BVs) in different adult organs has prompted the contention that
BVs are an indispensable component of SC niches (9–13). Al-
though an adequate vascular support is clearly essential for main-
taining proper SC function, whether SC function and output can be
further improved through targeted vascular manipulations has not
been examined.
In an attempt to produce long-lasting neurogenic increase per-
sisting in aged mice, we herein used a transgenic system designed
for brain-specific conditional (and reversible) VEGF gain of
function that expands and rejuvenates the niche vasculature (14).
VEGF is a highly pleiotropic factor shown to affect brain function
in many different ways, including increasing adult hippocampal
neurogenesis (reviewed in ref. 15). Here, we made extensive use of
a VEGF on/off switchable system for uncoupling VEGF functions,
requiring its ongoing signaling from functions primed by VEGF
but not requiring its continued presence, primarily functions at-
tributed to vasculatures laid down by VEGF.
Physical proximity between NSCs and BVs was demonstrated
per the two major neurogenic niches in the adult rodent brain,
namely, the subventricular zone (SVZ) and the hippocampal DG
(9–12). Per SVZ neurogenesis, a direct NSC-BV contact was shown
to be required (12, 16) to involve extracellular matrix signaling
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(11, 17) and ephrinB2/Jagged1 (16) or NT-3 signaling (18). Less is
known, however, regarding the nature of physical NSC-BV en-
gagements and communication modes in the DG niche.
Prompted by the view that the quiescent state of SCs, in
general, constitutes a poised state for activation by extrinsic fac-
tors (19) and by findings that young systemic factors can rescue
quiescence of aged stem and progenitor cells (20–22), we exam-
ined whether hippocampal NSC quiescence can be rescued by
cerebral VEGF gain-of-function despite continued exposure to
an “aged” systemic milieu.
Results
A Transgenic System for Conditional VEGF Induction Associated with
Expansion and Rejuvenation of the DG Vascular SC Niche. To expand
the vasculature in the vicinity of NSCs at the DG subgranular zone
(SGZ), VEGF165 was induced in this region. Briefly, calmodulin
kinase IIα (CaMKIIα) promoter-driven transactivator protein (23)
was used to induce VEGF165 conditionally by withdrawing tetra-
cycline from the drinking water (a scheme of the bitransgenic
system used is shown in Fig. S1A). A preparatory experiment using
a “responder” transgene encoding βGal reporter corroborated the
general utility of the CaMKIIα-tTA (tetracycline-transactivator)
driver to promote efficient expression of a responder gene of in-
terest throughout the hippocampus (in addition to other regions in
the adult brain) (Fig. S1B).
As previously published, VEGF induction elicited a robust an-
giogenic response evidenced by massive endothelial cell (EC)
proliferation and increase of microvascular density (MVD) already
detectable within a week from tetracycline withdrawal (14). VEGF-
induced added microvessels appeared to have a normal blood–
brain barrier (BBB) as judged by their pericyte coverage (Fig. S2A)
and a proper BBB function as determined by impermeability to
10 kDa of intracardially injected FITC-labeled dextran (Fig. S2B).
Increased MVD was associated with increased vascular complexity
(more bifurcation points) without an increase in vessel diameters
(Fig. S2C).
To follow phenotypes resulting from vascular expansion without
the confounding factors associated with ongoing ectopic VEGF
expression, VEGF was deinduced at the indicated time by
readding tetracycline (VEGF on>off protocol; the scheme of a
prototypic experiment is shown in Fig. S1D). VEGF ELISA and
quantitative PCR measurements secured that transgenic VEGF is
rapidly silenced and is undetectable within 2 wk from readding
tetracycline (14) (see Fig. 2B). Inspecting the DG vasculature
several months after VEGF deinduction indicated that vessels
induced by VEGF are durable (Fig. S1E). To provide a quanti-
tative estimate for the durability of VEGF-induced vessels, two
successive episodes of VEGF induction were exercised, separated
by an “off” period of several months (on>off>on protocol), in
conjunction with sequential pulsing with iodo-deoxyuridine (IdU)
and chloro-deoxyuridine (CldU) to tag actively proliferating ECs
differentially during each of the “on” cycles. Results not only
proved the feasibility of repetitive expansion/rejuvenation of hip-
pocampal vasculature but showed that previously generated ves-
sels are fully maintained as quiescent vessels for months (Fig. S1 F
and G). Long-term persistence of newly added vessels was further
evident by their presence 9 mo after VEGF withdrawal (Fig. S3).
Importantly, the ability of VEGF-induced hippocampal vascular
reinforcement was not blunted at an old age (discussed below).
VEGF-Induced Neurogenic Increase Is Proportional to the Magnitude of
Vascular Increase and Persists Months After VEGF Deinduction.We and
others have previously shown that experimental VEGF over-
expression leads to an increase in hippocampal neurogenesis (14,
24–26). Our previous findings that VEGF loss of function in the
adult hippocampus does not adversely affect hippocampal vessels
or neurogenesis and that VEGF is dispensable for basal DG
neurogenesis (14, 27) have suggested that the stimulatory effect of
VEGF might be attributed to VEGF-induced new vessels rather
than to a direct effect of VEGF on ECs and/or on nonvascular
cells expressing cognate receptors (24, 28–32). To examine this
proposition, we resorted to the use of the VEGF on>off strategy
and compared its effect with ongoing VEGF expression (on) (the
scheme is shown in Fig. 1A). VEGF led to a robust increase in DG
neurogenesis, as evidenced by a large increase in doublecortin
(DCX)-positive cells marking newborn neuroblasts. Remarkably,
the elevated level of neurogenesis did not subside following the
switching off of VEGF and proceeded at a high rate similar to the
one observed with ongoing VEGF induction, indicating that on-
going VEGF signaling is not required to maintain an increased
neurogenic level (Fig. 1 B and C). In fact, the elevated neurogenic
rate measured after VEGF withdrawal was identical to the level
measured during its continued presence; in both cases, the mag-
nitude of neurogenic increase was found to be proportional to the
increase in MVD (Fig. 1D).
Next, we determined whether augmented neurogenesis would
persist even after a more prolonged time following VEGF with-
drawal. To this end, VEGF was induced for 1 mo and then dein-
duced, and neurogenesis was examined 9 mo thereafter. Measuring
neurogenesis, either by counting new neurons added 1 mo before
euthanasia (identified as cells double-positive for CldU and the
panneuronal marker NeuN) or by measuring DCX+ neuroblasts,
indicated that up-regulated neurogenesis still exceeds the neuro-
genic level in littermate controls (Fig. S3).
VEGF Fails to Induce Long-Lasting Neurogenic Enhancement Unless
Accompanied by Formation of Durable Vessels. Data presented above
showing that ongoing VEGF expression is dispensable for long-term
persistence of enhanced neurogenesis are compatible with the no-
tion that the neurogenesis rate is governed by the added vascula-
ture. Nevertheless, we wished to rule out the possibility of some
irreversible, long-lasting effect of VEGF on nonvascular cells
expressing cognate VEGF receptors. It should be pointed out,
however, that contrary to other reports (24, 31, 32), we failed to
detect VEGF receptor 1 (VEGFR1) or VEGFR2 expression in
non-ECs within the DG (14). Here, we employed yet another ap-
proach of using a VEGFR2-GFP knock-in allele to confirm that
expression of this major VEGF signaling receptor is restricted to the
DG vasculature (Fig. S4 A–C). Further, EC-restricted VEGFR2
expression (detected by immunostaining) was also evidenced fol-
lowing VEGF induction (Fig. S4D). To prove an essential vascular
role, we took advantage of previous findings showing that newly
made vessels depend on VEGF for survival and regress if denied
VEGF before maturing into a VEGF refractory stage (33, 34).
VEGF was therefore induced for 1 wk only, a duration shown as
sufficient for new BV formation but insufficient for maintenance,
thus resulting in complete regression of newly formed BV shortly
after VEGF withdrawal (Fig. 2 A–C). Remarkably, no increase in
neurogenesis could be detected despite a week-long VEGF expo-
sure, strongly arguing that neurogenic increase is secondary to
VEGF’s angiogenic activity. Delaying VEGF withdrawal for an
additional week was indeed sufficient for generating lifelong dura-
ble neovessels in the DG and, correspondingly, for markedly in-
creased hippocampal neurogenesis (Fig. 2 D and E).
An independent, additional proof that the effects of VEGF on
neurogenesis are indeed mediated by the newly formed vessels was
obtained using a strategy of a sustained VEGF exposure together
with angiogenesis inhibition. Briefly, we used Lodamin, a modified,
improved version of TNP-470, a well-known antiangiogenic com-
pound developed by Folkman and coworkers (35). Its mode of
action was shown to be irreversible inactivation of methionine ani-
mopeptidase-2, leading to EC cycle arrest in late G1 phase (36) in a
clearly VEGF-independent mechanism. Lodamin was designed to
be impermeable to the BBB; therefore, it has no effect on brain
parenchyma (35). As shown in Fig. S5, Lodamin fully inhibited
VEGF-induced DG neovascularization and, remarkably, completely
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negated neurogenic enhancement by VEGF despite a continued
3-wk-long exposure to VEGF. Together, these findings strongly
support the conclusion that neurogenic enhancement by VEGF
preconditioning is mediated by VEGF-induced vascular changes.
Induction of VEGF in Old Mice and a Resultant Increase in MVD Up-
Regulates Already Subsided DG Neurogenesis. In the experiments
described above, we showed that VEGF induction associated with
vascular expansion at an early age has a profound effect on DG
neurogenesis at later stages, culminating in maintaining a “young”
neurogenic level in old mice. We next wished to determine whether
the aged hippocampus is still sufficiently plastic to elicit an angio-
genic response and to augment neurogenesis in response to VEGF
induction. To this end, we delayed the onset of VEGF induction to
progressively older ages and measured vascular and neurogenic
consequences of these manipulations (an experimental protocol is
shown in Fig. 3A). Results showed that VEGF responsiveness has
not blunted in the aged hippocampus, as evidenced by an efficient
neovascularization response and significant MVD increase (Fig. 3
B and C). Considering that microvascular rarefaction, a process
often accompanying natural aging in other organs, is insignificant in
the aged DG (Fig. 3C), any contribution of neovessels to neuro-
genesis might, in principle, be attributed to a vascular rejuvenation
effect. VEGF induction at any age examined led to a marked in-
crease in neurogenesis that again persisted after VEGF dein-
duction, as judged by enumeration of DCX+ neuroblasts (Fig. 3 B
and D) or by enumeration of newly generated mature neurons
(NeuN+ cells that have incorporated CldU) (Fig. S6). Although the
neurogenic output of the young (3–6 mo) hippocampus could not
be fully restored in the aged (9–16 mo) hippocampus, presumably
due to progressive age-related NSC loss (discussed below), the
apparent twofold to fivefold increase in neurogenic levels attained
by VEGF induction and preconditioning did not significantly differ
between young and old mice.
Using the fear-conditioning paradigm, we have previously
shown that VEGF overexpression improves memory and that this
effect is attributed to VEGF-induced increase of neuronal plas-
ticity rather than to its neurogenic effects (14). To determine
whether a short episode of VEGF exposure in aged mice is still
capable of enhancing learning, behavioral studies were conducted
on 1-y-old mice in which VEGF was preinduced for 2 wk. Results
clearly showed that VEGF induction at an old age is still capable
of improving learning (Fig. S7).
Neurogenic Enhancement by VEGF Manipulations Is Not Associated with
Accelerated NSC Depletion. Among possible causes for age-related
neurogenic decay is a progressive, activity-dependent NSC de-
pletion, reflecting the situation where a finite NSC pool can only
yield a correspondingly limited number of new neurons (2). Forced
neurogenic increase by either notch manipulation (6) or kainic acid
treatment (7) was indeed shown to accelerate NSC depletion. It
was of concern, therefore, that increased neurogenesis brought
about by VEGF and resultant vascular changes might also come at
the expense of premature NSC exhaustion and premature dimi-
nution of the neurogenic potential. Results described above
showing that maintaining a markedly elevated level of neurogenesis
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continually for months does not impede neurogenesis at an older
age (Figs. 1 and 2 and Fig. S3), to an extent, alleviated this concern.
To enumerate NSCs directly, NSCs were visualized with the aid
of an NSC transgenic reporter and unequivocally identified in
conjunction with their unique morphology (Fig. 4B). Briefly, a
nestin-GFP reporter transgene marking both NSCs and in-
termediate progenitor cells (IPCs) (but not further downstream
descendants) (37, 38) was bred onto the VEGF-switchable system,
and NSCs were identified in hippocampal sections as GFP+ cells
having their cell body embedded in the DG SGZ and their major
branch extending toward the granule cell layer (GCL) and termi-
nating with an arbor of dendrite-like branches [a morphology
earning these slow-dividing cells the name of radial glia-like cells
(RGLs)]. Quantification of RGLs in young (3 mo) and old (13 mo)
mice confirmed an age-related decline in total NSC number
(66,000 cells per cubic millimeter and 39,000 cells per cubic milli-
meter, respectively). Remarkably, RGL numbers did not decrease,
and even modestly increased, in VEGF-induced mice compared
with their age-matched controls (Fig. 4 C and G). These results
confirm that increased neurogenesis brought about by VEGF
manipulations is not associated with an accelerated NSC depletion.
VEGF Preconditioning Reduces Age-Related NSC Quiescence. Several
subprocesses in multistep neurogenesis might, in principle, be af-
fected by VEGF preconditioning and contribute to the apparent
overall neurogenic increase. This mechanism may involve pro-
cesses directly affecting NSCs, as well as downstream processes
associated with proliferation and/or survival of their descendants.
Here, we examined whether VEGF and associated vascular
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changes may impact age-related changes in NSC activation status.
To this end, IdU was injected (twice a day for 2 d) just before
euthanasia, and actively proliferating IdU+/GFP+ RGLs were vi-
sualized and quantified in DG sections. Note that in this procedure,
asymmetrically dividing RGLs are clearly discernible from sym-
metrically dividing IPCs (representative examples are shown in Fig.
4B and Fig. S8). In agreement with a previous report (4), a pro-
gressive age-related decline in the number of actively proliferating
RGLs was observed, enumerated here as 2,800 cells per cubic
millimeter at 3 mo but declining to 170 cells per cubic millimeter by
13 mo of age (Fig. 4D). This natural aging process was, however,
attenuated following VEGF treatments (Fig. 4D). To adjust for the
accompanying process of age-related NSC depletion, results are
also presented as the fraction of proliferating NSCs from the total
NSC reserve remaining at each respective age. Thus, whereas the
fraction of NSCs engaged in active proliferation dropped from a
calculated 5% in young mice to 1% by the time control mice have
reached 13 mo of age, such a decline was partially prevented in
VEGF-induced control littermates (Fig. 4E). Again, the increase in
the fraction of actively dividing NSCs was evident regardless of
whether VEGF was still on or was withdrawn 2 mo earlier.
To determine whether the increase in the percentage of active
NSCs persists for even longer after VEGF deinduction, VEGF was
induced for 2 wk and the hippocampus was examined 4 mo later.
In these 6-mo-old mice, RGL numbers were indistinguishable
from the RGL numbers of control littermates, but the percentage
of actively dividing RGLs was much higher than in age-matched
controls, 5% of total RGLs, the same number observed in young
(3-mo-old) animals (Fig. 4 F and G).
As expected, the increase in the fraction of RGLs engaged in
production of new neurons in older VEGF-manipulated mice was
accompanied by a parallel increase in the number of detected
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IdU+ IPCs in these mice (Fig. S8). We conclude that augmentation
of neurogenesis in aged mice consequent to VEGF precondition-
ing is, in large part, due to increasing the fraction of active NSCs.
VEGF Preconditioning Induces Changes in NSC Morphology and NSC-BV
Engagements. We wished to examine whether the vascular changes
induces a change in the unique cellular architecture of hippocampal
NSCs. To this end, confocal images of GFP-tagged RGLs, cos-
tained with CD31 to mark ECs, were examined. A dramatic change
in RGL morphology was noted as early as 5 d from switching on
VEGF and was even more pronounced with a longer VEGF ex-
posure. Most striking was a complete disappearance of the RGL
terminal arbor normally ending at the inner molecular layer and its
replacement with multiple long cytoplasmic extensions, some of
which reached further out into the DG molecular layer (Fig. 5A,
Left and Center and Fig. S9A). This morphological transition took
place in all RGLs, and in 30% of them, it also persisted for months
after VEGF withdrawal (Fig. 5C and Fig. S9A). Costaining with
GFAP, a marker distinguishing RGLs from IPCs [RGLs are
GFAP+, and IPCs are GFAP− (37)], confirmed that these mor-
phological changes indeed represent RGL transitions rather than
changes induced in IPCs (Fig. S9B). Intriguingly, this VEGF-
induced structural RGL transition resembles the configuration of
hippocampal RGLs detected in the postnatal brain (39) (Fig. 5A,
Right). Considering that the postnatal hippocampus is engaged in
more intense neurogenesis than the mature hippocampus, this re-
sult suggests that the RGL configuration induced by VEGF ma-
nipulations might be correlated with enhanced neurogenesis.
Next, we examined whether, similar to what has been reported
for SVZ NSCs (9, 16, 40) and, recently, for hippocampal RGLs (41,
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induction. (G) Quantification of RGLs per GCL volume unit and of the percentage of dividing RGLs when mice reached 6 mo of age. NS, not significant.
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42), communication between BVs and hippocampal NSCs involves
a direct contact between the two. Many of the long cellular process
extended by RGLs consequent to VEGF induction established
multiple direct contacts with ECs (Fig. 5 B–D). Newly made RGL-
EC engagements involved vessels distanced much further away
from the SGZ, where the RGL cell bodies are situated, but occa-
sionally also involved vessels in the opposite direction (Fig. 5C,
Center). Strikingly, upon contacting vessels, cytoplasmic extensions
extended by RGLs spread over them, creating button-like struc-
tures. The functional significance of induced BV-RGL contacts is
currently unclear.
These observations were reproduced through tagging RGLs in
Gli1-CREERT2::Ai9 tdTomato reporter mice. One month after
tamoxifen administration and VEGF induction, the same mor-
phological change and BV association were observed (Fig. 5D),
followed by their differentiation to DCX+ cells (Fig. 5E). Of note,
the morphological RGL changes induced by VEGF were not as-
sociated with the reactive phenotype induced by high-dose kainic
acid injection (7), because the latter has multiple short and thick
processes and differentiates into astrocytes, whereas BV-induced
NSCs have long and thin processes and undergo neuronal differ-
entiation (Fig. 5E).
Discussion
Although several growth factors were shown to be capable of
enhancing adult hippocampal neurogenesis, this study describes a
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Fig. 5. Structural NSC changes resembling a postnatal NSC configuration and NSC-BV contacts after VEGF preconditioning. (A) NSCs were visualized by nestin-
GFP expression in tritransgenic mice as described for Fig. 4. RGLs in a control 3-mo-old mouse (Left), RGLs in 3-mo-old VEGF mouse induced for the last month
(Center), and RGLs in control postnatal day 14 (p14) mice (Right). BVs are highlighted with CD31 staining. (Scale bar, 20 μm.) (B and C) Apical and distal contact
points between NSCs and BVs. Three-dimensional reconstructions of confocal images obtained with the aid of Imaris software highlighting direct contacts
between RGL processes (green) and BVs in a control animal (B) and following VEGF induction (C). Note spreading of terminal RGL processes over vessels,
creating button-like structures at contact points. RGLs make contacts with vessels residing in the molecular layer (1) and hilar vessels (2). (Right) Also note the
persistence of these structures following VEGF withdrawal. (Scale bars, 10 μm.) (D and E) NSC remodeling and NSC-BV contacts visualized using Gli1-creERT2 and
Ai9-tdTomato alleles bred into the VEGF switchable system. Mice were killed 1 mo after concomitant VEGF induction and tamoxifen administration allowing to
visualize both solitary RGLs (D) and clones of neuroblast descendants (E). Costaining with BVs and neuroblasts is shown. (Scale bars, 30 μm.)
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case where even an episodic, short exposure to a given factor is
sufficient to produce a long-lasting effect of enhanced neuro-
genesis persisting months after its withdrawal. This unprecedented
situation could, in principle, be attributed either to a direct, irre-
versible proneurogenic effect on NSCs or, alternatively, to a long-
lasting effect on the neurogenic microenvironment, which, in the
case of VEGF, is likely to involve the niche vasculature. Several
lines of evidence argue for the latter case. First, the neurogenic
increase is proportional to the increase in MVD regardless of
whether exposure to VEGF is episodic or continual. Second, the
direct effect on nonvascular cells is incompatible with our failure
to detect VEGF receptors, notably, the major signaling receptor
VEGFR2, on nonvascular cells in the adult DG. Third, exposure
to VEGF under conditions where newly added vessels were made
but were not sustained failed to increase neurogenesis. Fourth,
prolonged VEGF induction in the face of angiogenesis inhibition
(in a VEGF-independent manner) failed to increase neurogenesis.
Taken together, these results strongly argue for an indirect effect
mediated by neovessels laid down by VEGF. It should be pointed
out, however, that contrary to our failure to detect VEGF
receptors on nonvascular hippocampal cells, expression of
VEGFR2 on hippocampal NSCs has been recently reported (24,
31), arguing for a possible direct communication between VEGF
and NSC. In addition, it was shown that VEGF produced by
NSCs has a role in regulating neurogenesis (31). Reasons for the
discrepancy concerning VEGFR2 expression, presumed to re-
flect methodological differences, remain unclear. In any case, the
status of endogenous VEGFRs does not hamper the conclusion
that a short episode of VEGF exposure is sufficient to result in a
long-term neurogenic increase.
Interestingly, hippocampal neurogenesis was previously shown
to be increased by physical exercise and exposure to an enriched
environment (43, 44), stimuli also leading to an increase in MVD
(45), but it remains unclear whether these effects are interrelated.
Irrespective of the mechanism by which VEGF elicits a long-
lasting increase in neurogenic output, there was no trade-off in the
form of an accelerated exhaustion of the NSC reservoir as would
have been predicted by the SC disposal model (2), and as was
indeed observed when other modalities to increase DG neuro-
genesis were used (6, 7). Although the basis for this apparent
difference is currently unclear, this unique property of VEGF-
induced neurogenesis might be advantageous for intended long-
term increase of hippocampal neurogenic output.
Here, we show that neurogenic enhancement linked to vascular
ramification is associated with a dramatic change in SC mor-
phology. Remodeled NSCs are distinguished by long cytoplasmic
extensions terminating at the outer molecular layer instead of the
usual terminal arbor hanging loose in the inner molecular layer.
The role of the SC terminal arbor, if any, is currently unknown, but
it has been argued that it would be surprising for such an elaborate
structure not to function in the regulation of hippocampal NSCs
(46). The apparent affinity of remodeled cytoplasmic extensions to
BVs and the observation that they establish direct, stable contacts
with BVs are compatible with a direct vessel-NSC paracrine
communication. Notably, this spatial arrangement is also remi-
niscent of the situation in the SVZ neurogenic niche, where B1
cells extend specialized end-feet stretching out toward the vascu-
lature (9, 16, 40). Intriguingly, the particular NSC configuration
induced by vascular manipulations in the mature hippocampus is
similar to the configuration of NSCs found in the early postnatal
DG (39), and because the latter is engaged in significantly more
intense neurogenesis, it is tempting to speculate that this particular
NSC configuration is more compatible with a high neurogenic rate.
In principle, BVs may impact SC performance not only by virtue
of providing perfusion and distributing blood-borne factors but also
in a perfusion-independent manner via production of paracrinically
acting “angiocrine” factors (47–49). Could enhanced neurogenesis
be due simply to a quantitative increase of the niche vasculature or,
alternatively, to some qualitative change associated with vascular
“rejuvenation”? Embedded in the latter is the supposition of
“vascular aging” (i.e., that the niche vasculature undergoes age-
related changes compromising its ability to support proper SC
function). A recent study has indeed demonstrated qualitative age-
related changes in the vasculature of the bone osteogenic niche
that may compromise osteogenesis (50), and an age-related de-
crease in CD31 expression was noted in SVZ vasculature (22). Our
observation that the marked decrease in DG neurogenesis taking
place naturally between 3 and 16 mo of age is not associated with a
detectable vascular loss suggests that if neurogenic decrease is in-
deed due to failing vascular support, it must be primarily due to
vascular aging rather than to vessel rarefaction. Having shown that
rejuvenating the niche vasculature in old mice (in which neuro-
genesis has already mostly diminished) restores a high neurogenic
rate provides a rationale for the potential utility of vascular re-
juvenation. A recent study has demonstrated the feasibility of en-
hancing SVZ neurogenesis in old mice via heterochronic
parabiosis. The finding that this procedure was accompanied by
vascular remodeling prompted the conjecture by the authors of
neurogenic rejuvenation by vascular rejuvenation (22). However, it
remains to be determined whether neurogenic and vascular
changes are causally related and, importantly, whether neurogenic
enhancement can also be achieved by direct vascular rejuvenation
without the confounding factor of exposure to systemic factors
present in the young circulation. Results presented here demon-
strate that neurogenic enhancement at the DG niche can be
achieved directly by on-site vascular manipulation and can take
place despite continued exposure to an “old” systemic milieu.
Which facets of neurogenesis are positively affected by ectopic
VEGF? Several nonmutually exclusive mechanisms to be consid-
ered include expansion of the NSC pool, counteracting NSC
quiescence, additional rounds of neuroblast division, and in-
creasing neuroblast survival. Here, we only addressed the issue of
NSC quiescence and showed that naturally occurring, progressive
NSC quiescence can be significantly attenuated by VEGF. The
findings that VEGF preconditioning increases the fraction of ac-
tive NSCs without accelerating NSC disposal may explain the
sustained increase in neurogenesis also achievable at later ages.
Methods
Mice. All animal procedures were approved by the Animal Care and Use Com-
mittee of TheHebrewUniversity. The following transgenicmouse lineswere used
in this study. The CaMKIIα-tTA, Ai9, and Gli1-creERT2 lines were purchased from
The Jackson Laboratories. The pTET-VEGF164 responder line was as described
previously (14). Nestin-GFP mice (38) were obtained from G. Enikolopov (Cold
Spring Harbor Laboratory) (2, 38). VEGFR2-GFP/+ knock-in mice (51) were a
generous gift from A. Medvinsky, (University of Edinburgh). For switching off
VEGF, water was supplemented by 500 mg/L tetracycline (Tevacycline; Teva, Inc.)
and 3% sucrose. For switching on the transgene, tetracycline-supplemented
water was replaced by fresh water for the desired time. BrdU (50 mg/kg; Sigma),
CldU (100 mg/kg; MP Biomedicals), and IdU (100 mg/kg; Sigma) were injected i.p.
three times at 8-h intervals at the indicated time points before euthanasia. Ta-
moxifen (40 mg/mL in sunflower seed oil; Sigma) was administered orally once
daily for 3 d at a dose of ∼8 mg per animal. Lysine-fixable FITC-labeled dextran
(10,000 Da; Molecular Probes) was injected into the left ventricle at 0.1 g/kg
before euthanasia. Lodamin (30 mg/kg in water) was synthesized as de-
scribed (35) and given by oral gavage every other day for 3 wk. Animals
were housed in specific-pathogen-free housing conditions with irradiated
rodent food and water/tetracycline ad libitum. Both males and females
were used. Animals harboring CaMKIIα-tTA or pTET-VEGF164 alone served
as littermate controls for double-transgenic animals.
Immunofluorescence. Brains were fixed by immersion in 4% (wt/vol) para-
formaldehyde for 5 h, incubated in 30% (wt/vol) sucrose, embedded in OCT
(optimal cutting temperature) Tissue-Tec, and cryosectioned to 50-μm floating
coronal sections. Sections of the whole hippocampus were pooled but selected
before staining to represent all hippocampal areas in the rostral-caudal axis.
Staining was done as described (52) with the following: anti-GFP (1:400;
Abcam) anti-BrdU (1:200; Amersham), anti-CldU (1:400; Serotec), anti-IdU
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(1:200; Becton Dickinson), antilaminin (1:400; Neomarkers), anti-DCX (1:3,000;
Millipore), anti-CD31 (1:50; Becton Dickinson), anti-NeuN (Cell Signaling 1:600),
and anti-VEGFR2 (Cell Signaling 1:200). Cy5-conjugated extravidin, biotinylated
anti–guinea-pig, Cy2 anti-rabbit, Cy3 anti-mouse, and Cy2 anti-goat were all
from Jackson Immunoresearch (1:400 dilution).
Confocal Microscopy. Confocal microscopy was done using an Olympus FV-1000
on 20× and 40× air lens, with a 1.46-μm distance between confocal z-slices.
Three-dimensional reconstructions of z-stack scans were performed by Bit-
plane IMARIS 7.6.3 software. Volume and isosurface functions were used.
MVD Quantification. The z-stacks were processed using IMARIS 7.6.3 software.
An area of 318 × 318 × 22.5 μm, including the hilus, GCL, and molecular layer,
was analyzed. The surface function of the channel, including BV staining, was
conducted, and the total volume was calculated by the software. The ratio
between BV volume and the total region of interest was calculated.
Cell Density Quantification. The volumeof the GCL in every imagewasmeasured
by FV-1000 viewer software (Olympus) using DAPI staining. Quantification of
cells within this area (BrdU, CldU, or IdU) was done manually using the same
software by a blinded experimenter. Noteworthy, a month-long exposure to
VEGFwas not associatedwith a significant change inGCL volume, implying that
the relativenumber of cells calculatedper volumeunit is not skewedby changes
in GCL volume (Fig. S1C).
Statistical Analysis. All data are presented as mean ± SEM. For comparison
between two groups, the Student’s t test was used, and P values were cal-
culated in Excel (Microsoft) and SPSS 21.0 software (IBM) assuming two-
tailed distribution and unequal variances. Comparisons between multiple
groups were calculated by SPSS using one- or two-way ANOVA. At least four
images were taken for each animal, and the average per animal was used to
calculate the average of the experimental group. The numbers of animals in
every group and all statistical parameters for each experiment are presented
in Table S1.
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